Arbutus drags Pfizer, BioNTech to court over patent infringements
HQ Team April 5, 2023: Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team April 5, 2023: Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use.
HQ Team April 5, 2023: Johnson and Johnson, a US multinational making pharmaceuticals and medical devices, has offered to pay $8.9 billion to.
HQ Team April 4, 2023: About one in six people worldwide suffer from infertility, a disease that disables the male or female reproductive.
HQ Team April 3, 2023: Totto Learning, an India-based online parenting company, unveiled its artificial intelligence application, Cuddle, to support pregnant women and.
HQ Team April 3, 2023: Israeli researchers found that plants emit a distinct high-frequency sound similar to human speech that is beyond the.
Obesity is a global concern and the WHO maybe forced add obesity drugs to its essential medicine list
A man in India is the world's first documented case of a plant fungal infection.
Researchers from the University of Copenhagen in Denmark have found asymptomatic people with undetected obstructive coronary atherosclerosis increase their risk for a heart.
India has granted a complete customs duty exemption for the personal use of medicines to treat rare diseases, including Merc & Co’s Keytruda.
Aurobindo Pharma, an Indian maker of generic pharmaceuticals and active pharmaceutical ingredients, announced it signed a voluntary sub-licensing with a UN body for.